DEATH BY GRAFT-VERSUS-HOST DISEASE ASSOCIATED WITH HLA MISMATCH, HIGH RECIPIENT AGE, LOW MARROW CELL DOSE, AND SPLENECTOMY
- 1 July 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 40 (1) , 39-44
- https://doi.org/10.1097/00007890-198507000-00009
Abstract
In 65 recipients of marrow from HLA-identical siblings, the death rate from graft-vs.-host disease (GVHD) at 1 yr was 13%, which was significantly less when compared with 50% among 10 recipients of marrow from HLA-non-identical donors (P < 0.001 log-rank test). Among recipients of HLA-matched marrow the following was found: patients < 17 yr of age had a death rate from GVHD of 4% compared with 32% in elder patients (P < 0.01). In patients who received .gtoreq. 3 .times. 108 marrow cells/kg 3% died of GVHD compared with 31% in those receiving fewer marrow cells (P < 0.02). Furthermore, death by GVHD was 11% among nonsplenectomized patients compared with 60% in splenectomized patients (P < 0.001). Among all children, and among nonsplenectomized patients, those receiving < 3 .times. 108 marrow cells/kg had a significantly increased death rate by GVHD. The number of T cells or T cell subsets in the marrow graft was not correlated with GVHD or death by GVHD.This publication has 13 references indexed in Scilit:
- POSTSPLENECTOMY INFECTIONS IN DANISH CHILDREN SPLENECTOMIZED 1969–1978Acta Paediatrica, 1983
- Bone marrow transplantation for acute myelogenous leukemia. Factors associated with early mortalityJAMA, 1983
- MISMATCHED FAMILY DONORS FOR BONE-MARROW TRANSPLANTATION AS TREATMENT FOR ACUTE LEUKAEMIAThe Lancet, 1983
- Graft-versus-Host Disease and Survival in Patients with Aplastic Anemia Treated by Marrow Grafts from HLA-Identical SiblingsNew England Journal of Medicine, 1983
- EXPERIENCE WITH A COOPERATIVE BONE MARROW TRANSPLANTATION PROGRAM IN STOCKHOLMTransplantation, 1982
- A Randomized Study of the Prevention of Acute Graft-versus-Host DiseaseNew England Journal of Medicine, 1982
- MARROW TRANSPLANTATION WITH OR WITHOUT DONOR BUFFY COAT CELLS FOR 65 TRANSFUSED APLASTIC-ANEMIA PATIENTS1982
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979
- Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival.Journal of Clinical Investigation, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977